Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock enjoyed a major increase of 13.2% on 5/7/24. The shares closed at $5.48. Moreover, unusually high trading volume at 171% of normal accompanied the advance. The stock has risen 13.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, VNDA is expected to be Value Creation neutral.
Vanda Pharmaceuticals has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Vanda Pharmaceuticals has a slightly positive Appreciation Score of 69 but a slightly negative Power Rating of 31, with the Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment